Ooi T C, Twum-Barima Y
J Endocrinol Invest. 1987 Apr;10(2):107-9. doi: 10.1007/BF03347166.
A 44-year-old female with Cushing's disease associated with a pituitary macroadenoma was treated with cyproheptadine, 24 mg per day, after partial surgical resection of the tumor. A large residual tumor remained. There was no clear suppression of serum and urinary cortisol during therapy, but both levels rose markedly to beyond pre cyproheptadine levels, on withdrawal of the drug. This is the first report on the use of cyproheptadine in Cushing's disease associated with a pituitary macroadenoma. The response in this patient indicates an influence of cyproheptadine on ACTH secretion by the macroadenoma.
一名44岁患有库欣病且伴有垂体大腺瘤的女性患者,在肿瘤部分手术切除后接受了赛庚啶治疗,每日剂量为24毫克。术后仍残留一个大的肿瘤。治疗期间血清和尿皮质醇水平未得到明显抑制,但在停药后,这两个水平均显著升高,超过了服用赛庚啶前的水平。这是关于赛庚啶用于治疗伴有垂体大腺瘤的库欣病的首例报告。该患者的反应表明赛庚啶对大腺瘤促肾上腺皮质激素分泌有影响。